Development of a framework for metabolic pathway analysis-driven strain optimization methods by Vieira, Vítor et al.
Vol:.(1234567890)
Interdiscip Sci Comput Life Sci (2017) 9:46–55
DOI 10.1007/s12539-017-0218-7
1 3
Development of a Framework for Metabolic Pathway 
Analysis‑Driven Strain Optimization Methods
Vitor Vieira1 · Paulo Maia2 · Isabel Rocha1 · Miguel Rocha1  
Received: 21 July 2016 / Revised: 1 February 2017 / Accepted: 6 February 2017 / Published online: 25 February 2017 
© International Association of Scientists in the Interdisciplinary Areas and Springer-Verlag Berlin Heidelberg 2017
comparing robustness with a selected solution from a bi-
level CSOM.
Keywords Constraint-based modeling · Metabolic 
engineering · Pathway analysis · Minimal cut sets · Strain 
optimization
Abbreviations
List of Enzymes
ACOAH  Acetyl-CoA hydrolase
ATPS  atp synthase
G6PDH  Glucose 6-phosphate dehydrogenase
GAPD  Glyceraldehyde 3-phosphate dehydrogenase
NADH2  NADH dehydrogenase
PGK  Phosphoglycerate kinase
PYRDC  Pyruvate decarboxylase
SUCD2  Succinate dehydrogenase iron-sulfur protein
SUCD3  Succinate dehydrogenase cytochrome b
SUCD  Succinate dehydrogenase complex
List of Metabolites
훼 − kg  Alpha-ketoglutarate
atp  Adenosine triphosphate
dhap  Dihydroxyacetone phosphate
gaba  Gamma-aminobutyrate
nadh  Nicotinamide adenine dinucleotide (reduced)
nadph  Nicotinamide adenine dinucleotide phosphate 
(reduced)
nadp+  Nicotinamide adenine dinucleotide phosphate 
(oxidized)
Abstract Genome-scale metabolic models (GSMMs) 
have become important assets for rational design of com-
pound overproduction using microbial cell factories. Most 
computational strain optimization methods (CSOM) using 
GSMMs, while useful in metabolic engineering, rely on the 
definition of questionable cell objectives, leading to some 
bias. Metabolic pathway analysis approaches do not require 
an objective function. Though their use brings immedi-
ate advantages, it has mostly been restricted to small scale 
models due to computational demands. Additionally, their 
complex parameterization and lack of intuitive tools pose 
an important challenge towards making these widely avail-
able to the community. Recently, MCSEnumerator has 
extended the scale of these methods, namely regarding enu-
meration of minimal cut sets, now able to handle GSMMs. 
This work proposes a tool implementing this method as 
a Java library and a plugin within the OptFlux metabolic 
engineering platform providing a friendly user interface. 
A standard enumeration problem and pipeline applicable 
to GSMMs is proposed, making use by the community 
simpler. To highlight the potential of these approaches, 
we devised a case study for overproduction of succinate, 
providing a phenotype analysis of a selected strategy and 
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1 Introduction
In silico modelling of cell metabolism has become an 
important tool for understanding and manipulating bio-
chemical processes in living organisms. With recent 
advances in sequencing techniques, there has been an 
increase in the availability of sequenced whole-genomes. 
From these, a genome-scale metabolic model (GSMM) can 
be created using knowledge from annotations of metabolic 
genes. Such models can be used to predict cell behaviour 
and design intervention strategies to achieve certain goals. 
Metabolic engineering (ME), defined as the manipulation 
of cells with the purpose of achieving strains with desired 
phenotypes, benefits greatly from these approaches as it 
allows a rational design process as opposed to in vivo trial-
and-error methods [1].
There are two main approaches for metabolic modeling, 
namely constraint-based models (CBMs) and kinetic mod-
els. Kinetic models attempt to represent metabolite con-
centration over time, requiring enzyme rate laws that can 
accurately represent the dynamic behavior of the system. 
While such models tend to be more accurate, there is a lack 
of knowledge of enzyme kinetics and associated parame-
ters. CBMs, on the other hand, are more suited as GSMMs, 
adding assumptions regarding time, metabolite balance 
and enzyme kinetics to overcome the lack of knowledge of 
enzyme kinetics.
Phenotype prediction methods using CBMs are mostly 
based on flux balance analysis (FBA) first presented over 
two decades ago [2]. This approach has been applied and 
validated in a number of studies over the years [3] and 
attempts to find a flux distribution that is valid and satisfies 
a given cellular objective. This is normally defined as the 
maximization of an artificial flux representing cell growth. 
However, the validity of this objective is often disputed 
when modelling more complex or mutant cells, leading to 
the creation of alternative methods such as the minimiza-
tion of metabolic adjustment (MOMA) [4] and regulatory 
on/off minimization (ROOM) [5]. These methods attempt 
to find a flux distribution in mutant cells that is similar to 
the wild-type strain.
Strain optimization approaches based on the princi-
ples set by the FBA began to emerge. The goal with these 
approaches is to find suitable modifications to a given 
model that lead to desired phenotypes (such as compound 
production). The focus of this work concerns the usage of 
reaction deletions to overproduce valuable end compounds. 
In silico approaches for this purpose, computational strain 
optimization methods (CSOMs), can be split into two 
major branches.
Constraint-based (CB) CSOMs are based upon the prin-
ciples of FBA and employ a bi-level optimization approach. 
The outer optimization problem usually attempts to find an 
intervention strategy to the ME problem, while being sub-
ject to an inner optimization problem, which is normally 
a phenotype prediction method that optimizes towards the 
cellular objective (normally growth). OptKnock [6] was 
the first CB CSOM to employ this generic framework and 
many methods were developed based on it. These optimiza-
tion problems can also be solved with meta-heuristics, such 
as evolutionary algorithms (EA), as it is the case with Opt-
Gene [7] that first marked their usage in CSOMs.
Pathway analysis (PA) CSOMs, on the other hand, 
attempt to search for intervention strategies with methods 
that consider the entire solution space, describing all func-
tional units in the metabolic model rather than consider-
ing a fixed objective. As such, these methods provide an 
unbiased perspective on the theoretical limits of the whole 
model [8]. Most of these approaches rely on the concept of 
elementary flux modes (EFMs), representing the smallest 
sets of reactions representing cell functions in the model 
and minimal cut sets (MCSs) which correspond to sets of 
reactions blocking undesired EFMs. MCSs can be exploited 
by CSOMs to provide ME strategies with optimal size.
An early example of a CSOM employing EFM analysis 
is the FluxDesign algorithm [9], that determines correla-
tions between the cellular objective and the ME objective in 
a given set of EFMs and identifies up- and down-regulation 
targets based on this information. The CASOP framework 
[10] attempts to determine the relevance of each reaction to 
the ME objective through analysis of metabolic pathways 
described by selected EFMs. The end result is a ranking 
of reactions based on their potential for manipulation. The 
SMET approach attempts to find rate-limiting reactions and 
suitable intervention strategies with the purpose of increas-
ing the productivity of a given cell for a ME objective using 
knowledge from EFMs [11].
Enumeration of MCSs usually requires pre-calculated 
EFMs, with early approaches being based mostly on the 
Berge algorithm for graphs. With this approach, candidate 
MCSs are checked for their ability to disrupt the undesired 
flux space and their minimality. If these candidates comply 
with these conditions, they are added as MCSs [12, 13].
These methods attempt to eliminate the optimality bias 
that FBA-based approaches usually suffer from. However, 
the enumeration of all EFMs is needed to represent all of 
the capabilities of the cell and provide accurate results. This 
is a very computationally expensive process and mostly 
infeasible with GSMMs. Despite this, am MCS enumera-
tion method, MCSEnumerator, was recently proposed. It 
employs a MILP approach and allows partial enumeration 
of MCSs without requiring complete EFM enumeration. 
This method was validated with a GSMM of Escherichia 
coli, and was able to enumerate synthetic lethals up to five 
reactions, as well as several design strategies for relevant 
end-products [14].
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In this scenario, given the potential of MCS enumeration 
to guarantee robust production, regardless of the phenotype 
prediction method used, this work pursues the development 
of an open-source software tool capable of handling rele-
vant tasks in the MCS enumeration problem and applying 
those to strain optimization. Therefore, the main scientific/
are:
–– To implement a library compiling the necessary rou-
tines for enumeration of MCSs in CBMs.
–– To integrate MCS enumeration tasks in the OptFlux 
metabolic engineering platform, providing novel tools 
for strain optimization.
–– To provide a simple and intuitive user-interface for the 
implemented routines.
–– To describe predicted phenotypes using MCS-derived 
design strategies.
–– To compare MCSs with solutions from other 
approaches.
2  Methods
2.1  Constraint‑Based Models and Pathway Analysis
Constraint-based models of metabolism typically contain 
m intracellular metabolites and n reactions acting on them. 
Reactions can represent pools of external metabolites to 
simulate uptake or production of certain compounds. This 
model can be represented by a m × n matrix S, containing 
stoichiometric coefficients. Since CBMs assume metabolite 
concentrations are stable over time, this model leads to a 
system of linear equations:
with v as a vector containing fluxes (or rates) for each reac-
tion. Furthermore, thermodynamic or rate limits can be 
imposed upon the reactions, added as constraints in the fol-
lowing format:
with 훼 and 훽 being, respectively, the vectors containing 
lower and upper limits for the fluxes in v. An irrevers-
ible reaction j must have a lower limit 훼j = 0. The system 
defined by Eqs.  1 and 2 can be represented as a convex 
polyhedron hereby referred to as P, containing all feasible 
solutions to this system. Using this framework, the concept 
of elementary mode (EM) can be defined as representing 
a minimal functional unit within the model. Any elemen-
tary mode e equates to a flux distribution obeying three key 
properties [15]:
1. A flux distribution in e must comply with Eq. 1.
(1)S ⋅ v = 0
(2)훼 ≤ v ≤ 훽
2. Irreversible reactions must carry flux only through 
a single direction in any EM. These are specified in 
Eq. 2.
3. Considering supp(e) as the reactions carrying flux in e, 
no subset of supp(e) can yield a flux distribution obey-
ing Eqs. 1 and 2.
These approaches fully describe the polyhedron P, since 
any point contained within it is a linear combination of 
EMs. Desired flux distributions for the metabolic model 
can be found within non-null combinations of EMs within 
a desired set of flux vectors D.
Likewise, consider a set of undesired flux vectors T. Any 
set of reactions C that, when removed, can block the EMs 
contained in T is considered a cut set for T. If no subset of 
C can disable the EMs in T when blocked, C is considered 
a minimal cut set (MCS) [16]. However, the EMs in D are 
not guaranteed to remain active. If C, which is a MCS for 
T, does not block the EMs contained in D, it is considered a 
constrained MCS (cMCS) [17].
The definition of a ME problem for compound overpro-
duction usually aims at coupling production fluxes with 
growth rate, represented as an artificial reaction converting 
metabolites required for growth into biomass. This feature 
is defined as growth-coupled product synthesis (GCPS) 
[18] and can be classified in two ways depending on the 
degree of coupling. Assuming YB∕S as the biomass per sub-
strate yield, YP∕S as the product per substrate yield, pmin as 
the minimum desired product yield and bmin as the mini-
mum desired biomass yield:
–– Weak coupling occurs when YP∕S > pmin is always true 
if YB∕S > bmin.
–– Strong coupling occurs when YP∕S > pmin is true for all 
considered flux vectors.
2.2  Enumerating Minimal Cut Sets
MCS enumeration methods have usually relied upon 
exhaustively enumerating the full set of EMs and applying 
combinatorial algorithms using that knowledge. As pre-
viously stated, this is mostly infeasible for models at the 
genome-scale due to the heavy computational demand this 
task poses, since the number of EMs scales with the mod-
el’s complexity and size.
A recent approach, MCSEnumerator, circumvents this 
issue and allows enumeration of MCSs and cMCSs in 
GSMMs. Case studies using an E. coli GSMM resulted in 
compound overproduction strategies not greater than seven 
knockouts for various case studies, including serine, fuma-
rate and ethanol production [14]. The algorithm employs 
a mixed-integer linear programming (MILP) problem that 
combines two approaches from earlier work. The first is a 
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mathematical formulation in which a dual-system is gener-
ated so that EMs calculated in it correspond to the primal 
system in which it was based [19]. The second approach 
concerns the K-shortest algorithm for partial EM enumera-
tion, allowing enumeration of the smallest EMs using a 
simple MILP formulation [20]. By combining these two 
approaches, one can find the smallest EMs in the dual sys-
tem and thus, the smallest MCSs for the original model.
A generic pipeline based on the original publication was 
assembled, containing all the required steps for any given 
enumeration problem, as represented on the left panel of 
Fig.  1. Model compression (pre-processing phase) and 
MCS decompression are optional steps, but largely improve 
computation times. The MILP problem and basic algorithm 
for MCS enumeration are represented on the right panel of 
the previous figure.
3  Development
There are two key end-results regarding the software devel-
oped for this work. First, a Java library containing the MCS 
enumeration pipeline was implemented using the MCSE-
numerator approach. The second end-result is a plugin for 
the OptFlux platform, developed to provide a user interface 
for the Java library.
3.1  Enumeration Library
MCSEnumerator was made available as a part of the Cell-
NetAnalyzer platform currently available for MATLAB. 
One of the aims of this work was the development of a 
standalone library containing the necessary resources to 
solve MCS enumeration problems using the MCSEnumera-
tor algorithm [14]. This library was built using the Java 
programming language to allow greater compatibility with 
most platforms and enable the use of advanced tools for the 
development of a graphical user interface (GUI). This soft-
ware currently relies on the IBM ILOG CPLEX Optimiza-
tion Studio to solve the MILP problem described in [14].
This library contains three newly developed packages:
1. Enumeration Contains methods needed to implement 
the MCSEnumerator MILP formulation, given a suit-
able problem.
2. Metabolic Provides a framework upon which CB mod-
els can be defined, as well as constraints for typical 
linear programming problems such as yield or capacity 
constraints on the reactions.
3. Utilities Includes methods that execute the entire 
pipeline given a set of parameters for the optimiza-
tion. Functions to run the algorithms in a command-
line environment are also provided, capable of reading 
parameters contained within text files.
● Import metabolic network
● Determine unbounded fluxes
● Identify pseudo-reactions
● Set target reactions
● Find blocked reactions
● Compress model
● Set desired and undesired 
phenotypes
● Assess feasibility
● Enumerate MCS
● Decompress MCS
● Convert to cMCSs
Model setup
Pre-processing
Problem setup
Enumeration
1
2
3
4
S' v'
0
S v 0
≥
0=
=
irreversible
reactions
reversible
reactions
E = {}
m = maximum solution size
for i in {1, … m}
● set constraint: EM size to i
● enumerate all dual EMs
● E = {E, set of valid EMs}
● add constraint: EMs cannot be a 
subset of any EM in E
return E
conversion to 
dual model
Fig. 1  Left representation of the pipeline used in this work. Step (1) 
concerns model setup which consists mainly on determining reac-
tion reversibility and pseudo-reactions that will not be a part of any 
solution; Step (2) aims at reducing the size of the problem, mostly 
through removal of blocked reactions and network compression by 
lumping correlated reactions. Step (3) assembles the enumeration 
problem and validates it, so that in Step (4) the proper formulation 
is built and solved. MCSs that are not feasible in the desired space 
are discarded, leaving only cMCSs. Right brief overview of the MILP 
formulation. S′ and v′ are derived from the dual model formulation in 
[19] which already includes the undesired phenotypes
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The libraries provide routines capable of executing these 
tasks in a command-line environment using only a meta-
bolic model in Systems Biology Markup Language 
(SBML) format and a file containing the parameters of the 
MCS enumeration problem, which may include undesired 
or desired limits for fluxes or yields, exclusion of target 
reactions, among other constraints. The source code for this 
library as well as resources to run the case studies featured 
in this article can be found on a public repository at https://
github.com/MEWorkbench/mcslibrary.
3.2  OptFlux Plugin
This work also aimed at providing a simple and clear user 
interface (GUI) as a plugin within OptFlux [21]. Cur-
rently, this framework includes important tools used in 
CB approaches, including phenotype simulation, analysis 
methods, and strain optimization algorithms developed in-
house (OptGene [7] and derivatives [22]).
As far as this work is concerned, OptFlux provides the 
necessary methods to read and write metabolic models, 
serving as inputs for our algorithms.
The developed plugin provides a simple GUI (repre-
sented on Fig. 2 for the MCSEnumerator approach requir-
ing minimal user input and providing a useful abstraction 
for the concepts discussed in the previous section. The user 
is only required to specify the maximum number of knock-
outs, which reactions correspond to biomass, product syn-
thesis and substrate uptake, the desired thresholds for pro-
duction and growth, and whether the production threshold 
is a yield or a rate constraint. Additionally, environmental 
conditions can be added and knockout targets can be dis-
carded from the search either by supplying a list of critical 
reactions or a gene ID corresponding to spontaneous reac-
tions; should the model represent those as being associated 
with a placeholder pseudo-gene?.
The solutions are displayed using OptFlux’s GUIs, using 
the format of previously available optimization algorithms. 
So, these solutions can be processed and simulated after-
wards using other tools from OptFlux. OptFlux can be 
downloaded from http://www.optflux.org/. This plugin is 
available in the software’s plugin repository as “Minimal 
cut set enumeration plugin for OptFlux”, and is already 
included in the base installation from version 3.3 onwards.
Fig. 2  Graphical interface provided by the plugin to formulate an enumeration problem
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4  Results
4.1  Library Validation
The set of case studies was defined with the aim of ensuring 
that the outputs provided by the developed software match 
the ones from MCSEnumerator’s original implementation. 
As such, the iAF1260 E. coli GSMM [23] was used with 
different enumeration problems for which the cMCSs were 
previously determined in the original publication [14]. The 
results from all case studies were accurately replicated and 
are highlighted in the Table 1.
4.2  Plugin Operation
This section shows in more detail the plugin’s mode of 
operation using one of the case studies described above 
(ethanol anaerobic production in E. coli using glucose as 
carbon source). To run this case study:
1. Start a new OptFlux project using the New project 
wizard option on the File tab, click on OptFlux model 
repository and select the iAF1260 E. coli model. 
Assume default options in the process.
2. Create an environmental condition using the New... 
menu, option Create... and then click Environmental 
condition. Add a constraint for reaction R_EX_glc_e 
with lower bound as −20 and upper bound as 999,999 
(definition of glucose uptake rate), and another for R_
EX_o2_e_ with 0 as lower bound and 999,999 as upper 
bound (definition of anaerobic conditions).
3. Access the Optimization tab, and click on Minimal 
cut sets.
(a) Select the environmental condition that was cre-
ated in the previous step.
(b) Allow at most 3 modifications and set the sponta-
neous ID for s0001.
(c) Set the objective configuration as follows:
–– Biomass as R_Ec_biomass_core_59p81M
–– Substrate as R_EX_glc_e_
–– Product as R_EX_etoh_e_
(d) Set the biomass value to 0.1, choose yield and 
then set the minimum product value to 0.2.
This example allows determination of 3 reaction deletions, 
guaranteeing a minimum ethanol per glucose yield of 0.2 
and ensuring any solution determined maintains this pro-
duction with a minimum growth rate of 0.1 h−1. The results 
can be browsed and sorted and also saved to disk as a text 
file. Specific solutions (deletion sets) can be saved to the 
clipboard, and simulated or analyzed through other Opt-
Flux tools.
5  Case Study
To prove the usefulness of the integrated framework, a case 
study is presented involving overproduction of succinate in 
the yeast Saccharomyces cerevisiae in a glucose-rich, aero-
bic medium. Design strategies for this task were enumer-
ated using the MCSEnumerator implementation featured in 
this work and the Strength Pareto Evolutionary Algorithm 
(SPEA2) as CSOMs. For a closer comparison between both 
methods, the same target reactions were used. This was 
achieved through a list of reactions forbidden from being 
knocked-out, which was determined prior to this work. 
This list represents a set of reactions that compromise cell 
growth if knocked-out, and is specific to the environmental 
conditions that we attempt to replicate. Both sets of strate-
gies are compared through analysis of the predicted pheno-
types of a selected solution from both sets.
Table 1  Overview of the 
validation case studies
Y represents product/substrate yield and Glc represents glucose uptake (mmol gDW−1 h−1). Note that aero-
bic conditions were allowed only for fumarate and serine production. Computation times were determined 
using 12 processor cores and 30 GB of RAM
Objective Scenario #MCS/#cMCS Computation 
time (h)
Maxi-
mum 
size
Synthetic lethals – 1018/– 17 4
Anaerobic ethanol production Glc ≤ 10 Y ≥ 1.4 185,302/8342 7.5 7
Glc ≤ 10 Y ≥ 1.8 153,338/1987 9.1 7
Glc ≤ 18.5 Y ≥ 1.4 156,477/8819 12.7 7
Glc ≤ 18.5 Y ≥ 1.8 138,675/4618 2 7
Fumarate production Y ≥ 0.5 Glc ≤ 20 17338/30 12.4 7
Serine production 18,449/140 1 6
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5.1  Problem Formulation
As there are two strategy groups featured in this section, 
we hereby name MCSEnumerator solutions as cMCSs 
(constrained minimal cut sets), while SPEA2 solutions are 
termed EA (evolutionary algorithm).
Model A modified version of the iMM904 model recon-
struction of S. cerevisiae [24] was chosen for this work. 
This model was chosen as it was already subject to previ-
ous work, being more consistent when predicting experi-
mentally determined phenotypes [25].
SPEA2 The SPEA2 algorithm [26] chosen to represent 
CB methods. It is a multi-objective optimization algorithm 
incorporating concepts initially used in OptGene [7]. Simi-
larly to other bi-level heuristic frameworks, the inner prob-
lem pertains the assessment of the quality of the solution. 
However, unlike other algorithms, it can assume multiple 
objectives. In this case, the objective is the maximization 
of two objective functions, namely biomass and product 
flux. Parsimonious FBA (pFBA) [27] is used to obtain both 
these values.
Since this is an evolutionary algorithm, a pool of solu-
tions is evolved until the algorithm stops. A cap of 100,000 
objective function evaluations was applied as a stopping 
criterion and the algorithm was run 10 times. Solutions 
could not exceed 20 knockouts. A total of 331 distinct solu-
tions were found.
MCSEnumerator Parameters used to build the enumera-
tion problem for use with our implementation are described 
in Table 2. 1451 constrained minimal cut sets were success-
fully determined using this parameterization.
5.2  Phenotype Analysis
This section will focus on the changes on predicted phe-
notypes after applying constrained minimal cut sets to the 
model. An individual solution was selected (Solution 1 in 
Table  3) so that its phenotype could be further explored. 
The criteria for its selection was size, as it is beneficial for 
in vivo implementation purposes that the strategies contain 
the least number of knockouts. The goal is to find whether 
cMCSs can be based on other solutions from CB methods.
The selected solution highlighted on Table  3 (Solution 
1) was decomposed and its predicted pFBA phenotype 
was determined. All possible combinations of knock-
outs using this solution were determined and simulated 
with the aim of determining the smallest set of knock-
outs allowing minimum product flux above a threshold of 
10−4 mmol gDW−1 h−1 at any minimum biomass fraction. 
Within these subsets, a solution was identified (WCS1 on 
Table 3) as appearing in the set of EA solutions.
5.2.1  Weakly Coupled Succinate Production
With two solutions from both sets, first we attempt to 
describe the phenotype of the smaller solution from the EA 
set by applying two different maximum biomass restric-
tions (90 and 100%) along with the knockouts and predict-
ing the corresponding phenotypes.
Sub-optimal biomass At 90% of the maximum biomass, 
there is a marked increase in acetate production from pyru-
vate, yielding reducing power (nadh) and protons over the 
wild type. In Fig. 3, the increased fluxes in cytosolic path-
ways, as well as the reduced flux through citrate synthase, 
show a metabolic shift from cell respiration to acetate 
production. As a result, there is little carbon for succinate 
production. Low flux values in mitochondrial NADH2 can 
be explained by the almost absent flux in tricarboxilic acid 
Table 2  Parameters and 
settings used in the enumeration 
problem to achieve succinate-
producing solutions
Glc and Succ represent, respectively, glucose and succinate exchange from the external medium to the cell. 
Biomass is the growth pseudo-reaction. ATPM is the maintenance ATP flux
Parameter Value
Undesired phenotypes Glc ≥ −1.15 mmol gDW−1 h−1
Succ/Glc ≥ −0.0001
Desired phenotypes Biomass ≥ 0.0001 mmol gDW−1 h−1
Glc ≥ −1.15 mmol gDW−1 h−1
Succ/Glc ≤ −0.0001
Maximum solution size 9
Excluded reactions 1177
Forced uncompressed reactions Drains, biomass and ATPM
Table 3  Knockout strategies 
considered in the phenotype 
analysis
Abbreviation Knockouts
WCS1 {SUCD2; 
SUCD3; 
G6PHD }
Solution 1 WCS1 ∪ 
{ACOAH; 
PYRDC 
;PGK}
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(TCA) cycle, with nadh being mostly produced in the cyto-
sol as a result of acetate production. Even so, atp is still 
produced in the mitochondria since the proton gradient is 
maintained by cytosolic NADH2 activity.
Optimal biomass Once biomass restrictions are lifted, 
there is less free carbon in the cell and pyruvate is no 
longer converted to acetate. In terms of atp production, it 
is still lower than wild type (WT), but is higher than the 
previous scenario. There is less nadh being produced out-
side the mitochondria since there is no fermentative pro-
cess occurring. Oxaloacetate is produced outside the mito-
chondria (by pyruvate carboxylase) and enters it through 
the oxaloacetate-malate shuttle with nadph production. 
Ultimately, it is converted to 훼 − Kg with production of 
exported to the cytosol through exchange with malate. Out-
side the mitochondria, it is converted to glutamate through 
catalysis by glutamate dehydrogenase (nadp+ forming). 
With the WCS1 at optimal biomass, TCA cycle flux is 
necessary for succinate production to occur through this 
pathway.
5.2.2  Strongly Coupled Succinate Production
With the WCS1 applied to the model, to achieve strong 
growth coupling, there must be a set of knockouts that can 
block pathways to which carbon can be diverted away from 
succinate production. Comparing with the WCS1 scenario 
at 90% biomass, acetate production from pyruvate is one of 
these pathways. Two of the exclusive knockouts in Solution 
1 are reactions involved in acetate and ethanol fermenta-
tive synthesis (ACOAH and PYRDC). However, blocking 
fermentation isn’t enough for strong coupling. The strongly 
coupled phenotype can only occur with the addition of a 
final knockout, PGK or GAPD (correlated reactions). The 
differences in growth coupling are represented in Fig.  4, 
while an overview of the overall phenotype predicted 
to occur after the knockouts in Solution 1 is depicted in 
Fig.  5. This difference in growth-coupling repeats itself 
when comparing any two solutions from both sets.
Comparing with the WCS1 phenotype at the same 
biomass restrictions, it is predicted that glycolysis is dis-
rupted due to the knockout at the payoff phase. Glucose 
is thus converted into two dhap molecules at the end of 
the preparatory phase. The methylglyoxal pathway is 
now essential for pyruvate formation since it converts 
dhap to lactate (over a series of reactions), and this lac-
tate is converted to pyruvate by lactate dehydrogenase. 
Fig. 3  Comparison between 
different knockout scenarios 
based on Solution 1. C stands 
for cytosolic enzyme, while 
M stands for mitochondrial 
enzyme. C/M represents 
enzymes whose activity occurs 
across membranes. The sce-
narios included in this analysis 
are: WT for wild type, WCS90 
for the WCS knockout set 
under a 90% maximum biomass 
restriction, WCS for the WCS 
knockout set without restric-
tions and SCS for the Solution 1 
knockout without restrictions
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Fig. 4  Chart depicting the production envelope for the WCS and 
Solution 1 knockout simulations. The lines show the minimum and 
maximum boundaries for succinate excretion as a function of the 
lower bound imposed on the biomass flux
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Shifting carbon through this pathway only produces 1 
nadh per dhap molecule, with no atp production. Since 
there is no atp produced from cytosolic reactions, it must 
be produced inside the mitochondria by atps. acoah and 
pyrdc knockouts are likely needed so that there isn’t 
any viable steady state fulfilling the desired phenotypes 
other than one carrying flux through the tca cycle.
Regarding the respiratory chain, there is a decrease 
in cytochrome oxidoreductase and an increase in 
cytochrome oxidase flux. Oxygen uptake and cytochrome 
oxidase activity is increased in this phenotype. Concur-
rently, there is also an increase in NADH2 flux inside the 
mitochondria, which is inactive in the cytosol. There is a 
greater amount of carbon going in the malate–oxaloac-
etate shuttle and thus arriving at the gaba shunt, which 
also increases the succinate yield. Full coupling may 
occur since carbon is forced in the TCA cycle to allow 
cell growth, as atp is no longer produced in the cytosol. 
atp production occurs but succinate production must 
also occur since carbon in the cycle cannot be converted 
into fumarate through succinate.
6  Conclusions and Further Work
The availability of PA-based strain design methods is 
scarce when considering GSMMs. The new library pro-
posed in this work presents a useful resource for the meta-
bolic engineering community, allowing for the enumeration 
of MCSs, in a way that is fit for most problems with generic 
CB models, while also allowing flexibility regarding prob-
lem setup.
The proposed OptFlux plugin facilitates an abstraction 
from complex concepts surrounding cMCS enumeration, 
improving ease of use and extending the already wide vari-
ety of optimization algorithms within OptFlux, maintaining 
a coherent overall computational interface. Also, the pro-
vided software is all made available to the community as 
open source allowing for third party contributions in the 
future.
As far as utility is concerned, it is demonstrated that 
predicted production robustness in MCS approaches is 
superior despite carrying the cost of lower maximum cell 
growth when compared with alternative CB methods. This 
Fig. 5  Overview of the pFBA 
flux distribution predicted for 
Solution 1. The boxes represent 
reactions responsible for a given 
conversion (closest arrow) and 
their flux value, with green 
arrows representing active 
fluxes on Solution 1. Crosses 
represent knockouts, with 
orange crosses corresponding to 
WCS1 knockouts and red ones 
representing knockouts exclu-
sive to Solution 1 that are not 
present in the WCS1 solution
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elicits the need for more research into the in  vivo feasi-
bility of strongly coupled designs, which will ultimately 
establish the viability of minimal cut set-based approaches 
altogether.
Despite all efforts, the library is still dependent on 
a commercial solver, but that provides a free academic 
license. Computation times for larger sets of deletions, even 
when using a state-of-the-art optimizer, can be time con-
suming for some enumeration problems, and others still 
remain out of reach. Heuristic methods or alternative for-
mulations may help in achieving solutions for larger sizes 
and this will be a line of future work.
Acknowledgements The authors thank the project “DeYeastLi-
brary—Designer yeast strain library optimized for metabolic engi-
neering applications”, Ref. ERA-IB-2/0003/2013, funded by national 
funds through “Fundação para a Ciência e Tecnologia / Ministério da 
Ciência, Tecnologia e Ensino Superior”.
References
 1. Stephanopoulos G (1999) Metabolic fluxes and metabolic engi-
neering. Metab Eng 1(1):1–11
 2. Varma A, Palsson BO, Arbor A, Varma A (1994) Stoichiometric 
flux balance models quantitatively predict. Appl Environ Micro-
biol 60(10):3724–3731
 3. Orth JD, Thiele I, Palsson BØ (2010) What is flux balance analy-
sis? Nat Biotechnol 28(3):245–248
 4. Segrè D, Vitkup D, Church GM (2002) Analysis of optimality 
in natural and perturbed metabolic networks. Proc Natl Acad Sci 
USA 99(23):15112–15117
 5. Shlomi T, Berkman O, Ruppin E (2005) Regulatory on/off mini-
mization of metabolic flux changes after genetic perturbations. 
Proc Natl Acad Sci USA 102(21):7695–7700
 6. Burgard AP, Pharkya P, Maranas CD (2003) Optknock: a bilevel 
programming framework for identifying gene knockout strat-
egies for microbial strain optimization. Biotechnol Bioeng 
84(6):647–657
 7. Patil KR, Rocha I, Forster J, Nielsen J (2005) Evolutionary 
programming as a platform for in silico metabolic engineering. 
BMC Bioinform 6:308
 8. Schilling CH, Schuster S, Palsson BO, Heinrich R (1999) Meta-
bolic pathway analysis: basic concepts and scientific applications 
in the post-genomic era. Biotechnol Prog 15(3):296–303
 9. Melzer G, Esfandabadi M, Franco-Lara E, Wittmann C (2009) 
Flux design: in silico design of cell factories based on correlation 
of pathway fluxes to desired properties. BMC Syst Biol 3(1):120
 10. Hädicke O, Klamt S (2010) CASOP: a computational approach 
for strain optimization aiming at high productivity. J Biotechnol 
147(2):88–101
 11. Flowers D, Thompson RA, Birdwell D, Wang T, Trinh CT 
(2013) SMET: systematic multiple enzyme targeting—a method 
to rationally design optimal strains for target chemical overpro-
duction. Biotechnol J 8(5):605–618
 12. Haus U-U, Klamt S, Stephen T (2008) Computing knock-out 
strategies in metabolic networks. J Comput Biology: J Comput 
Mol Cell Biol 15(3):259–268
 13. Jungreuthmayer C, Beurton-Aimar M, Zanghellini J (2013) Fast 
computation of minimal cut sets in metabolic networks with a 
Berge algorithm that utilizes binary bit pattern trees. IEEE/ACM 
Trans Comput Biol Bioinform 10(5):1329–1333
 14. von Kamp A, Klamt S (2014) Enumeration of smallest interven-
tion strategies in genome-scale metabolic networks. PLoS Com-
put Biol 10(1):e1003378
 15. Schuster S, Hilgetag C (1994) On elementary flux modes 
in biochemical reaction systems at steady state. J Biol Syst 
02(02):165–182
 16. Klamt S, Gilles ED (2004) Minimal cut sets in biochemical reac-
tion networks. Bioinformatics 20(2):226–234
 17. Hädicke O, Klamt S (2011) Computing complex metabolic inter-
vention strategies using constrained minimal cut sets. Metab Eng 
13(2):204–213
 18. Klamt S, Mahadevan R (2015) On the feasibility of growth-
coupled product synthesis in microbial strains. Metab Eng 
30:166–178
 19. Ballerstein K, von Kamp A, Klamt S, Haus U-U (2012) Minimal 
cut sets in a metabolic network are elementary modes in a dual 
network. Bioinformatics 28(3):381–387
 20. de Figueiredo LF, Podhorski A, Rubio A, Kaleta C, Beasley JE, 
Schuster S, Planes FJ (2009) Computing the shortest elementary 
flux modes in genome-scale metabolic networks. Bioinformatics 
25(23):3158–3165
 21. Rocha I, Maia P, Evangelista P, Vilaça P, Soares S, Pinto JP, 
Nielsen J, Patil KR, Ferreira EC, Rocha M (2010) OptFlux: an 
open-source software platform for in silico metabolic engineer-
ing. BMC Syst Biol 4(1):45
 22. Rocha M, Maia P, Mendes R, Pinto JP, Ferreira EC, Nielsen J, 
Patil K, Rocha I (2008) Natural computation meta-heuristics for 
the in silico optimization of microbial strains. BMC Bioinform 
9(1):499
 23. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, 
Karp PD, Broadbelt LJ, Hatzimanikatis V, Palsson BØ (2007) A 
genome-scale metabolic reconstruction for Escherichia coli K-12 
MG1655 that accounts for 1260 ORFs and thermodynamic infor-
mation. Mol Syst Biol 3(121):1–18
 24. Mo ML, Palsson BØ, Herrgård MJ (2009) Connecting extracel-
lular metabolomic measurements to intracellular flux states in 
yeast. BMC Syst Biol 3(1):37
 25. Pereira R, Nielsen J, Rocha I (2016) Improving the flux distribu-
tions simulated with genome-scale metabolic models of Saccha-
romyces cerevisiae. Metab Eng Commun 3:153–163
 26. Maia P, Rocha I, Ferreira EC, Rocha M (2008) Evaluating evolu-
tionary multiobjective algorithms for the in silico optimization of 
mutant strains. In: 8th IEEE international conference on bioIn-
formatics and bioEngineering, BIBE 2008
 27. Carreira R, Evangelista P, Maia P, Vilaça P, Pont M, Tomb J-F, 
Rocha I, Rocha M (2014) CBFA: phenotype prediction integrat-
ing metabolic models with constraints derived from experimen-
tal data. BMC Syst Biol 8(1):123
